ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

Cancer Advocates Ask House By Byspass Budget; NCCR’s Day Calls For $380 Mil. Minimum Increase

March 12, 1993

In Brief: Radiation Therapy Pioneer Juan Del Regato Dead At 90

July 16, 1999

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011